A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma.
Fulciniti M, Hideshima T, Vermot-Desroches C, Pozzi S, Nanjappa P, Shen Z, Patel N, Smith ES, Wang W, Prabhala R, Tai YT, Tassone P, Anderson KC, Munshi NC.
Fulciniti M, et al. Among authors: hideshima t.
Clin Cancer Res. 2009 Dec 1;15(23):7144-52. doi: 10.1158/1078-0432.CCR-09-1483. Epub 2009 Nov 24.
Clin Cancer Res. 2009.
PMID: 19934301
Free PMC article.